Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$951,184
-$22,438 QoQ
Shares Held
12,771
-2.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#233
of 469 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SYON CAPITAL LLC holds $10,838,405 across 29 Biotechnology names. BBIO ranks #2 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,640 | $1,808,097 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
This page
|
12,771 | $951,184 | |
| 3 | ARGX |
Argenx SE
|
1,017 | $943,542 | |
| 4 | INCY |
Incyte Corp
|
6,409 | $726,524 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
9,782 | $538,010 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
857 | $534,373 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
6,115 | $531,699 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
964 | $517,619 |
All Filings in BBIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $951,184 | 12,771 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $973,622 | 13,111 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,007,449 | 13,171 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $684,101 | 13,171 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $568,507 | 13,166 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $455,079 | 13,164 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $362,208 | 13,200 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||